Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.

Lise M, Nitti D, Buyse M, Cartei G, Fornasiero A, Guimaraes dos Santos J, Duez N

Istituto di Patologia Chirurgia 1a, Universita degli Studi di Padova, Italy.

Recent Results Cancer Res. 1988;110:36-43. doi: 10.1007/978-3-642-83293-2_5.

Abstract

摘要

相似文献

Recent Results Cancer Res. 1988;110:36-43. doi: 10.1007/978-3-642-83293-2_5.

Anticancer Res. 1989 Jul-Aug;9(4):1017-21.

Recent Results Cancer Res. 1988;110:212-8. doi: 10.1007/978-3-642-83293-2_33.

J Clin Oncol. 1995 Nov;13(11):2757-63. doi: 10.1200/JCO.1995.13.11.2757.

Ann Oncol. 2002 Nov;13(11):1779-85. doi: 10.1093/annonc/mdf302.

Cancer Treat Rep. 1983 May;67(5):421-4.

Med Oncol Tumor Pharmacother. 1989;6(2):171-4. doi: 10.1007/BF02985241.

Nouv Rev Fr Hematol (1978). 1990;32(3):207-9.

Cancer. 1993 Jun 15;71(12):3813-8. doi: 10.1002/1097-0142(19930615)71:12<3813::aid-cncr2820711205>3.0.co;2-5.

JAMA. 1985 Apr 12;253(14):2061-7.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。